Afatinib monotherapy in EGFR-mutant lung adenocarcinoma

被引：0
|
作者：
Gilbert, Judith A.
机构：
来源：
LANCET ONCOLOGY | 2013年 / 14卷 / 09期
关键词：
D O I：
10.1016/S1470-2045(13)70346-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E345 / E345
页数：1
相关论文
共 50 条
  • [1] Afatinib—new therapy option for EGFR-mutant lung cancer
    Helena A. Yu
    William Pao
    Nature Reviews Clinical Oncology, 2013, 10 : 551 - 552
  • [2] Ibrutinib Treatment and EGFR-mutant Lung Adenocarcinoma
    Shulman, Katerina
    Kazarin, Olga
    Tannous, Elias
    Sofer, Orit
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2021, 23 (06): : 385 - 386
  • [3] Resistance to Afatinib and Cetuximab Combination Therapy in EGFR-mutant Lung Adenocarcinomas
    Pirazzoli, Valentina
    Takezawa, Ken
    de Stanchina, Elisa
    Pao, William
    Politi, Katerina
    CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [4] Management of stage IA EGFR-mutant adenocarcinoma of the lung
    Pirker, Robert
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S3260 - S3262
  • [5] Capmatinib and Osimertinib Combination Therapy for EGFR-Mutant Lung Adenocarcinoma
    Gautschi, Oliver
    Menon, Roopika
    Bertrand, Miriam
    Murer, Christian
    Diebold, Joachim
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (01) : E13 - E15
  • [6] The clinicopathological and molecular characteristics of resected EGFR-mutant lung adenocarcinoma
    Zhou, Wensheng
    Liu, Zhichao
    Wang, Yanan
    Zhang, Yanwei
    Qian, Fangfei
    Lu, Jun
    Wang, Huimin
    Gu, Ping
    Hu, Minjuan
    Chen, Ya
    Yang, Zhengyu
    Zhao, Ruiying
    Lou, Yuqing
    Han, Baohui
    Zhang, Wei
    CANCER MEDICINE, 2022, 11 (05): : 1299 - 1309
  • [7] Progression of EGFR-Mutant Lung Adenocarcinoma is Driven By Alveolar Macrophages
    Wang, Don-Hong
    Lee, Hyun-Sung
    Yoon, David
    Berry, Gerald
    Wheeler, Thomas M.
    Sugarbaker, David J.
    Kheradmand, Farrah
    Engleman, Edgar
    Burt, Bryan M.
    CLINICAL CANCER RESEARCH, 2017, 23 (03) : 778 - 788
  • [8] Circulating tumour DNA genomics in EGFR-mutant lung adenocarcinoma
    Rosell, Rafael
    Karachaliou, Niki
    LANCET RESPIRATORY MEDICINE, 2018, 6 (09): : 649 - 651
  • [9] Clinical outcomes of leptomeningeal metastases in EGFR-mutant lung adenocarcinoma
    Shen, C-I.
    Chiu, C-H.
    ANNALS OF ONCOLOGY, 2019, 30
  • [10] Acquired ALK Rearrangement in EGFR-Mutant Lung Adenocarcinoma Treated with EGFR TKIs
    Wang, Q.
    Chen, R.
    Kang, J.
    Chen, H.
    Wang, B.
    Wang, Z.
    Zhou, Q.
    Wu, Y.
    Yang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S569 - S570
12345